Clinical trial

Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus…

NCT00474136 · Javelin Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00474136
Title Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium
Official title Open-Label, Randomized, Single Center Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses) Versus Oral Diclofenac Potassium in Healthy Adult Volunteers Following Single- and Multiple-Dose Administration
Lead sponsor Javelin Pharmaceuticals, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Healthy
Intervention type Drug
Interventions Intravenous diclofenac sodium (DIC075V) 18.75 mg, Intravenous diclofenac sodium (DIC075V) 37.5 mg, Oral diclofenac potassium 50 mg
Enrollment 36
Start date Mar 1, 2007
Primary completion May 1, 2007
Completion May 1, 2007
First posted May 16, 2007
Last update posted Jan 4, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies